Clinical trials
Phase 1 Hypogonadism trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2013 | 3 |
| 2014 | 4 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Terminated | 5 |
| Withdrawn | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 6 |
| Repros Therapeutics Inc. | 3 |
| Acerus Pharmaceuticals Corporation | 2 |
| Solvay Pharmaceuticals | 2 |
| Stephanie B. Seminara, MD | 2 |
| The University of Texas Medical Branch, Galveston | 2 |
| University of Washington | 2 |
| AbbVie | 1 |
| Acerus Biopharma Inc. | 1 |
| Acrux DDS Pty Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypogonadism | 37 |
| Kallmann Syndrome | 4 |
| Eunuchism | 3 |
| Infertility, Male | 2 |
| Anemia, Sickle Cell | 1 |
| Erectile Dysfunction | 1 |
| Frailty | 1 |
| Gonadal Dysgenesis | 1 |
| Hyperprolactinemia | 1 |
| Kidney Diseases | 1 |
Trials
Showing 51 to 37 of 37. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.